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Background: Anxiety disorders are highly prevalent in primary care and cause a substantial burden of disease.
Screening on risk status, followed by preventive interventions in those at risk may prevent the onset of anxiety
disorders, and thereby reduce the disease burden. The willingness to participate in screening and interventions is
crucial for the scope of preventive strategies, but unknown. This feasibility study, therefore, investigated
participation rates of screening and preventive services for anxiety disorders in primary care, and explored reasons
to refrain from screening.
Methods: In three general practices, screening was offered to individuals visiting their general practitioner (total
n = 2454). To assess risk status, a 10-item questionnaire was followed by a telephone interview (including the CIDI)
when scoring above a predefined threshold. Preventive services were offered to those at risk. Participation rates
for screening and preventive services for anxiety disorders were assessed. Those not willing to be screened
were asked for their main reason to refrain from screening.
Results: Of all individuals, 17.3% participated in initial screening, and of those with a possible risk status, 56.0%
continued screening. In 30.1% of those assessed, a risk status to develop an anxiety disorder was verified. Of these,
22.6% already received some form of mental health treatment and 38.7% of them agreed to participate in a
preventive intervention and were referred. The most frequently mentioned reasons to refrain from screening were
the emotional burden associated with elevated risk status, the assumption not to be at risk, and a lack of
motivation to act upon an elevated risk status by using preventive services.
Conclusions: Screening in general practice, followed by offering services to prevent anxiety disorders in those at
risk did not appear to be a feasible strategy due to low participation rates. To enable the development of feasible
and cost-effective preventive strategies, exploring the reasons of low participation rates, considering involving
general practitioners in preventive strategies, and looking at preventive strategies in somatic health care with
proven feasibility may be helpful.
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Anxiety disorders are prevalent, often have a chronic
course, and are associated with functional limitations.
Given these features, preventing the development of
anxiety disorders seems a good strategy. Hence, screen-
ing of individuals on risk factors and early stages of the
disorder offers the opportunity to provide preventive* Correspondence: n.batelaan@ggzingeest.nl
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reproduction in any medium, provided the orinterventions, and thereby limit the disease burden for
both the individual and the society.
Some decades ago, Wilson and Jungner identified cri-
teria defining situations in which screening on risk fac-
tors and early stages of the disorder is appropriate [1]
(Table 1). Based on these criteria, screening on risk fac-
tors and subclinical anxiety is indeed warranted. First,
anxiety disorders are one of the most common psychi-
atric disorders with a lifetime prevalence of approxi-
mately 20% [2-4] and an annual incidence rate of 3%
among adults [5]. They are regarded an important healthl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Assessment criteria for screening [1]
1 The condition sought should be an important health problem.
2 There should be an accepted treatment for patients with
recognized disease.
3 Facilities for diagnosis and treatment should be available.
4 There should be a recognizable latent or early symptomatic stage.
5 There should be a suitable test or examination.
6 The test should be acceptable to the population.
7 The natural history of the condition, including development from
latent to declared disease, should be adequately understood.
8 There should be an agreed policy on whom to treat as patients.
9 The cost of case-finding (including diagnosis and treatment of
patients diagnosed) should be economically balanced in relation
to possible expenditure on medical care as a whole.
10 Case-finding should be a continuing process and not a “once and
for all” project.
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functional limitations [6,8,9]. Related to their chronic
course, comorbid disorders often occur [10], thereby
negatively impacting on the outcome. Second, effective
preventive interventions based on cognitive behavioural
treatments are available [11-16]. It is plausible that these
interventions are acceptable for those at risk because
interventions are not associated with any hazard and can
be provided according to the individuals’ preference, i.e.
in an individual format, a group intervention or a format
using the internet. Third, screening implies that risk fac-
tors for anxiety disorders are known and can be assessed
accurately. Previously, we defined target groups for the
prevention of anxiety disorders, in which the largest
public health benefit for the lowest effort can be
achieved [17]. These target groups consist of individuals
1) with a (subthreshold) panic attack in the past year,
2) with an affective disorder in the past year, or 3) with a
history of anxiety disorders combined with low mastery.
These target group characteristics can be assessed rela-
tively simple and without any risks involved, i.e. by a self
report questionnaire and a telephone interview. Given
the substantial costs associated with anxiety disorders
[18], case-finding and subsequent treatment may well be
cost-effective.
Given the assessment criteria, screening on high risk
groups for the development of anxiety disorders is thus
both appropriate and possible. However, the level of will-
ingness of primary care patients to participate in screen-
ing and in interventions to prevent anxiety disorders is
unknown. It is imaginable that some individuals refrain
from screening because the knowledge of being at risk
may be emotionally stressful. Likewise, using preventive
services implicates not only time investment, but also a
continuous confrontation with being at risk. In addition,
in individuals visiting primary care, prevention of anxiety
disorders may not be on their (somatic) agenda.Participation in screening and preventive interventions
is crucial with regard to the population health benefit
that can be achieved by preventive strategies, and with
regard to the cost-effectivity of such strategies. Given
the importance of participation rates for large scale im-
plementation of preventive strategies, we conducted a
study assessing the willingness of individuals for screen-
ing and preventive interventions in primary care.
In three general practices, screening was offered to
patients visiting their general practitioner (irrespective of
the reason for their visit). When risk status appeared
present, a preventive intervention of their choice was
offered. We investigated the proportion of individuals
willing to be screened, and the proportion willing to
accept a preventive intervention in those at risk.
Methods
In 2010 and 2011, we consecutively offered screening in
three general practices located in Amsterdam, Leiden and
Almere, thereby covering different regional parts of the
Netherlands. Screening was offered free of charge to any
individual between 18 and 65 years old who spoke suffi-
ciently Dutch when visiting their general practitioner, irre-
spective of the reason of their visit. Trained research
assistants offered a package to all visitors, including an in-
formation letter, the question whether they were willing to
be screened for their risk status to develop an anxiety dis-
order in the oncoming year, a few questions regarding
socio-demographics, and the initial screening questions.
Individuals could either fill in the questions directly while
waiting, or could fill them in at home and return the pack-
age in a postage-paid envelope.
The information letter included information about the
frequent occurrence of anxiety disorders, the availability
of effective preventive interventions, the possibility to
assess their risk status, and the procedure.
The research proposal has been approved by the Eth-
ical Review Board of VU-University Medical Center. The
Ethical Review Board concluded that, given that the re-
search used fully disidentified data only, informed con-
sent was not required. The information letter provided
to all potential participants described that disidentified
data would be used to assess the willingness for screen-
ing and interventions to prevent anxiety disorders.
If patients refrained from screening, they were asked
to provide several socio-demographic characteristics
(gender, age, education), and were asked to report the
reason of their refusal. If patients agreed to be screened,
questions regarding social-demographics were followed
by 10 screening questions. These aimed to identify those
high-risk groups for the development of anxiety disor-
ders we mentioned in the introduction: individuals
1) with a (subthreshold) panic attack in the past year,
2) with an affective disorder in the past year, or 3) with a
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[17]. To screen for panic attacks and affective disorder,
we used screening questions regarding panic and depres-
sive mood from the Web-based Screening Questionnaire
(WSQ;[19]). The WSQ is a questionnaire screening for
the presence of common mental disorders. Symptoms
during the past year were included. Validated cut-off
scores of the WSQ were used. To screen for anxiety dis-
orders in the past, two questions were formulated. The
first asked for anxiety problems in the past, the second
whether these anxiety problems had resulted in limited
functioning or suffering or had resulted in seeking treat-
ment. Finally, mastery was assessed using an adapted ver-
sion of the Mastery Scale [20], including 5 items. The total
score provides information about the degree of control
one assumes to have over his life. In correspondence with
previous research [17,21], low mastery was defined as a
score lower than or equal to 18. A possible high risk status
was regarded present if individuals reported positively on
1) the screening question of panic attacks, or 2) the
screening question on depressive mood, or 3) on the ques-
tions regarding anxiety problems in the past that had
resulted in limited functioning or suffering or for which
treatment was indicated, combined with low mastery.
If a high risk status was absent, individuals were
informed per email or per post (depending on their pre-
ference). It was thereby mentioned that the future onset
of an anxiety disorder could not be ruled out based on a
screening. Individuals scoring positively on the initial
screening questions were regarded as having a possible
high risk status because the screening questions provide
insufficient assurance of a proper selection of people at
high risk for two reasons. First, based on a screening
question the presence of a fully developed anxiety dis-
order cannot be ruled out. Second, there is a risk of false
positives because the WSQ is over inclusive [19].
In individuals with a possible high risk status, initial
screening questions were therefore followed by a tele-
phone interview. These individuals were, therefore con-
tacted within two weeks. If necessary, individuals were
contacted at different times a day up till at least five
times by telephone, and once by post. A psychologist
conducted the telephone interview, consisting of the sec-
tion on anxiety disorders (past year and lifetime), and on
depressive disorders (past year only) of the Composite
International Diagnostic Interview (CIDI), version 2.1
[22]. The CIDI is a valid and reliable instrument to diag-
nose psychiatric disorders and can be conducted by
trained lay interviewers [23]. If the interview verified the
high-risk status (and verified the absence of a fully devel-
oped anxiety disorder), a suitable preventive intervention
was offered. This could either be assisted self help, inter-
net interventions, a group intervention, or regular treat-
ment for a depressive disorder.Results
In 2010 and 2011, screening was offered to 2536 indivi-
duals visiting their general practitioner, (see Figure 1),
1500 in Amsterdam, 403 in Leiden and 633 in Almere.
When screening had been offered to the majority of
individuals visiting their general practitioner, screening
was ended. Forty-three individuals reported to have been
diagnosed with an anxiety disorder. In addition, 39 indi-
viduals mistakenly received the package but were
excluded later based on age limits or language problems.
The target population for screening thus consisted of
2454 individuals.
Of these 2454, 424 individuals (17.3%) completed
the questionnaire. This proportion differed significantly
between the three general practitioners offices: 14.6%
in Amsterdam, 21.5% in Leiden en 21.1% in Almere (X2
(df = 2) = 18.42; p < 0.001). Of those screened, 63.9%
was female, 34.4% male (1.7% missing data), the mean
age was 40.5 years (SD 14.0 years)(0.5% missing data);
4.5% only had basic education, 55.9% secondary general
education or intermediate vocational education, and
37.8% had higher vocational or scientific education
(1.9% missing data).
The other 2030 individuals either explicitly refused to
be screened (‘explicit refusers’; n = 861) or did not return
the questionnaire (‘implicit refusers’; n = 1169).
Socio-demographic characteristics were provided by
23.4% (n = 468) of all refusers.
Age, gender and educational level did not differ signifi-
cantly between these refusers and those who completed
the screening questionnaire (gender p = 0.31; age p =
0.25; education p = 0.45). In addition, 25.7% (n = 522)
provided information about the reason to refuse screen-
ing, see Table 2. The most important reasons to refrain
from screening were a lack of motivation for preventive
interventions (34.9%), emotional burden associated with
the presence of a risk status (19.7%), and not considering
themselves at risk (17.8%).
Of the 424 individuals who completed the question-
naire, 43.4% (n = 184) scored positively on the initial
screening, and were therefore eligible for further screen-
ing by a telephone interview, administered to 56.0% (n =
103). The remaining individuals either refused further
screening (40.2%; n = 74) or could not be reached (3.8%;
n = 7).
Of the 103 individuals who completed the telephone
interview with the CIDI-sections anxiety and depression,
29.1% (n = 30) already fulfilled criteria of an anxiety dis-
order, and were advised to seek regular treatment. In
40.8% (n = 42) a heightened risk status could not be veri-
fied, and in the remaining 30.1% (n = 31) a risk status for
the onset of anxiety disorders was present. The most
commonly diagnosed target group for prevention con-
sisted of depressive disorders. Of those with a verified
Not willing further 
screening
n=74 (40.2%)
No risk status
n=42 (40.8%)
Willing further 
screening
n=103 (56.0%)
Screening offered 
n=2536
Known with an 
anxiety disorder
n=43
Implicit refusers
n=1169 (47.6%)
Target population
n=2454
Above cut-off score
n=184 (43.4%)
Under cut-off score
n=240 (56.6%)
Risk status n=31 (30.1%)
Panic attack n=6
Depression n=19
History anxiety disorder and low 
mastery n=1
Multiple risk factors n=5
Motivated for an 
intervention
n=12 (38.7%)
Not motivated for an 
intervention
n=12 (38.7%)
Explicit refusers
n=861 (35.1%)
Screening
n=424 (17.3%)
Anxiety disorder 
present
n=30 (29.1%)
Exclusion
n=39
Total refusers n=2064 (82.7%)
Cannot be reached
n=7 (3.8%)
Receiving mental 
health treatment
n=7 (22.6%)
Figure 1 Flowchart screening.
Table 2 Reasons provided to refuse screening (n = 522)
Reasons n %
No motivation for a preventive intervention 182 34.9
Emotional burden associated with potential
risk status
103 19.7
Other: 237 45.4 n %
Do not consider themselves at risk 93 17.8
Do not find it necessary because they are
familiar with anxiety disorders
14 2.7
Objection to provide personal data 4 0.8
Do not feel intervention is necessary until
anxiety disorder is present
12 2.3
Logistic objections 17 3.3
Not interested 25 4.8
Not specified 72 13.8
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ment, 38.7% refused psychiatric treatment despite the
verified risk status and a similar proportion expressed
willingness for an intervention and was referred
(Figure 1).
Discussion
In theory, the prevention of anxiety disorders appears a
good strategy to diminish the burden of disease because
anxiety disorders are prevalent and severe, screening on
risk status can be conducted safely and effective prevent-
ive interventions are available. Moreover, screening for
mental disorders has been successfully provided by
trained lay interviewers [24]. Such a procedure may limit
costs for screening. The importance that individuals at-
tach to prevention, and their willingness to participate in
Table 3 Possible causes of low participation rates in
preventive interventions, see [24]
Participants - Individuals do not consider themselves as being at risk.
- Individuals do not see themselves as having
subthreshold complaints because symptoms are labelled
differently.
- Individuals do not believe that preventive interventions
are effective.
- Individuals are not willing to participate because of the
stigma associated with mental disorders.
- Individuals do not want to participate in a group
intervention, or have coinciding commitments at the
time of the sessions.
Organization - The positioning of preventive services within mental
health care may limit the familiarity with these services
among potential participants and general practitioners.
Recruitment - Potential participants may not be aware of the
existence of preventive services if communication to
recruit participants does not reach potential participants.
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participation rates in both screening and preventive
interventions impact on the disease burden that can be
prevented, and on the cost-effectivity of preventive strat-
egies. In the current study the participation rates of
screening and preventive interventions with regard to
anxiety disorders were assessed by offering screening to
2454 individuals of three general practices, and by offer-
ing preventive interventions to those at risk.
We may conclude that the feasibility of the prevention
of anxiety disorders in primary care was poor: only a mi-
nority of the target population was willing to be
screened: 17.3% for initial screening, and of those with a
possible risk status 56.0% was motivated for further
screening. Of those with a verified risk status, some
already received mental health treatment, and some
were not motivated to undergo treatment despite the
knowledge of being at risk. Thus, offering screening to a
large number of individuals resulted in providing pre-
ventive interventions in only a few individuals.
To our knowledge, participation rates in screening and
interventions aiming to prevent anxiety disorders have
not been assessed before. With regard to the present
study, several limitations should be taken into account.
First, offering screening in only three general practices
may have reduced generalizability of the findings; par-
ticipation rates of screening differed significantly be-
tween these practices. However, in none of the practices
participation rates were near sufficient to make screen-
ing a feasible option. Second, findings cannot be general-
ized to other preventive programs, because recruitment
methods may impact on participation rates. Third, limited
data is available about individuals who refrained from
screening, because most of them did not return the screen-
ing list. As a result, other reasons to refrain from screen-
ing than those mentioned above cannot be ruled out.
Despite these limitations, findings of the present study
do not stand alone, but correspond with findings regard-
ing the prevention of depressive disorders in which only
about 1% of those eligible participated in preventive
interventions [25]. Cuijpers and colleagues presented an
overview of possible causes of low participation rates
[25] (Table 3). Some of the potential causes they describe
can be ruled out in the present study: we explicitly
reported on risk status thereby excluding unawareness as
potential cause, we explained that preventive interventions
are effective, mentioned the availability of several prevent-
ive interventions, including internet interventions which
allow people to follow the intervention at their own pace,
and we provided contact addresses to start an intervention
of the individuals’ preference. The timing of recruiting
participants may have been unsuitable in the present study
as potential participants were waiting for their general
practitioner to discuss another problem. However, theprocedure allowed taking the questionnaire home and
returning it later. Given low participation rates when
recruiting in the general practitioners office, one could
consider other modes of recruitment, such as recruiting
participants through systematic screening in the popula-
tion or via the internet. Because the general practitioner
himself was not involved in recruiting participants in the
present study, one could also hypothesize that endorse-
ment by general practitioners may improve participation
rates, for example, by discussing a potential stigma or by
mentioning potential negative consequences of anxiety
disorders, including those on cardiovascular function [26].
The two-step procedure might also have discouraged po-
tential candidates. However, this does not seem very likely
given that most individuals refrained from screening be-
fore taking notice of the procedure. In the present study,
emotional burden associated with a potential risk status
appeared to be the main reason to refrain from screening.
This may well be related to perceived stigma. Alonso and
colleagues showed that those with an anxiety disorder fre-
quently feel embarrassed or discriminated related to their
mental health [27], and Cuijpers and colleagues [25] sug-
gested stigma as a cause of low participation rates. Other
frequently reported reasons to refrain from screening were
the assumption not to be at risk of developing an anxiety
disorder, and a lack of motivation to use preventive ser-
vices. It can be hypothesized, that lack of knowledge
regarding risk factors and regarding the severity of anxiety
disorders may impact upon participation rates. If so, in-
creasing knowledge on anxiety disorders might encourage
individuals to participate in screening and prevention.
Conclusions
Whereas theoretically, screening and prevention of anx-
iety disorders may substantially reduce the disease
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of the disease burden cannot be capitalized if participa-
tion rates in screening and preventive services are low,
as was found in the present study. Given the potential
benefits, and given the high participation rates in some
somatic screening programs such as screening for breast
cancer [28], we should not refrain from further attempts
to prevent the onset of anxiety disorders. To enable the
development of feasible and cost-effective preventive
strategies, exploring the reasons of low participation
rates, considering involving general practitioners in pre-
ventive strategies, and looking at preventive strategies in
somatic health care with proven feasibility may be
helpful.
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